Login to Your Account



Organogenesis Pioneers

CBER Pathway for Allogeneic Product Approval Emerges

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, March 19, 2012

In 1998, Organogenesis Inc. received approval for its first allogeneic product, Apligraf, from the FDA's Center for Devices and Radiological Health (CDRH).

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription